Healthcare Services

Addictions Therapeutics Market Expansion Outlook Through 2030 With Revenue Growth Insights

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Increase In Market Value Is Predicted For The Addictions Therapeutics Market During The 2026–2030 Period?

The market for addictions therapeutics has demonstrated robust growth in recent years. This expansion is set to continue, as it is forecast to increase from $7.46 billion in 2025 to $7.93 billion in 2026, advancing at a compound annual growth rate (CAGR) of 6.2%. Several factors contributed to its growth during the historic period, including the increasing prevalence of substance use disorders, rising awareness about addiction treatment, the growing number of specialized treatment centers, the adoption of buprenorphine and naltrexone therapies, and the expansion of hospital and clinical networks.

The addictions therapeutics market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $10.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.6%. This expansion during the forecast period is attributable to the development of innovative addiction therapeutics, increased government and private funding for suds programs, the rise of telehealth and digital treatment platforms, the growing integration of mental health and addiction therapies, and the broadening of public-private partnerships in addiction care. Significant trends for the forecast period include a rising demand for medication-assisted treatment (mat), the expansion of both inpatient and outpatient addiction treatment centers, greater adoption of telehealth and remote counseling services, an intensified focus on nicotine and opioid addiction therapies, and enhanced awareness programs for substance use disorders.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

What Major Growth Factors Are Impacting The Addictions Therapeutics Market?

A rise in alcohol intake is anticipated to drive the expansion of the addiction therapeutics market moving ahead. The term “alcohol consumption” denotes the act of consuming drinks that contain ethyl alcohol. Addiction therapeutics serve in the treatment of alcohol addiction, helping individuals reduce their alcohol intake. This is achieved by counteracting the depressive impacts of alcohol and fostering equilibrium between the excitatory and inhibitory neurotransmitters, namely glutamate and gamma-aminobutyric acid, within an individual. Consequently, this leads to a decrease in alcohol cravings, easing and suppressing symptoms like insomnia, anxiety, and restlessness that are linked with alcohol withdrawal. As an illustration, in December 2024, information from Kirin Holdings Co. Ltd., a company from Japan specializing in alcoholic, non-alcoholic beverages, and pharmaceutical products, indicated that worldwide beer consumption in 2023 experienced a minor increase of roughly 200,000 kl compared to 2022. This brought the total to approximately 187.9 million kl, which is equivalent to about 296.9 billion 633 ml bottles, signifying a slight annual growth of 0.1%. Consequently, the growing intake of alcohol is fueling the addiction therapeutics market.

How Does Segment Analysis Break Down The Addictions Therapeutics Market Structure?

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse, Generic Disulfiram

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix), Generic Varenicline

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

What Trends Are Affecting The Addictions Therapeutics Market Dynamics?

Leading companies within the addiction therapeutics market are innovating products like drugs for cocaine use disorders (CUD) to cater to a broader customer base, increase sales, and boost revenue. These drugs for cocaine use disorders (CUD) are medications designed to aid individuals grappling with cocaine addiction or dependence. For example, in January 2023, Tempero Bio, a US-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for the TMP-301. The key feature of TMP-301, the Company’s investigational compound, is its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Purposefully developed for a significant role in treating cocaine use disorders (CUD), TMP-301 is distinguished by its potency, selectivity, and oral availability, all aimed at effectively reducing the excessive glutamate signaling associated with CUD.

Who Are The Prominent Players Across The Addictions Therapeutics Market?

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Access The Complete Addictions Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Region Accounts For The Highest Share Of The Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Addictions Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp

Browse Through More Reports Similar to the Global Addictions Therapeutics Market 2026, By The Business Research Company

Substance Abuse And Addiction Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Nicotine Addiction Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report

Substance Abuse And Addiction Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795